Introduction
Cannaworx, founded by Dr Bobby (Babak) Ghalili, DMD and Dr. Adrienne Denese, M.D. Ph.D, has developed an extensive portfolio of consumer products, which include FDA cleared, patented/ patent pending diverse products that capitalize on disruptive delivery systems in the areas of pain relief, pharmaceuticals, skincare, nutraceuticals and agricultural/veterinary products.
OTC Medicine
FDA cleared legal pain claim and immune booster products, using Phytocannabinoid delivery
Pharmaceuticals
CanaGelMD is the only cannabinoid-containing oral preparation with a legal, FDA cleared pain claim
Nutraceuticals
We deliver ingestible or transdermal products with greater bio and absorb ability
Skin Care / Cosmetics
Our Sativa Oil (Hemp) based skincare line sold $250,000 in 10 mins on QVC (Dec 2019)
Leadership
Dr Bobby (Babak) Ghalili, DMD
Chairman, Chief Science Officer
One of the foremost periodontal and reconstructive dental surgeons in the field, he is an Associate Professor of Periodontal Surgery at New York University and the University of Medicine and Dentistry of New Jersey. Dr. Ghalili is a graduate of Brandeis, Tufts, and UMDMJ, and author of 21 patents (6 awarded patents and 15 patent pending).
Dr. Adrienne Denese, M.D. Ph.D.
Director, Chief Marketing Officer
Dr Denese, M.D., Ph.D. (Cornell, Harvard) has been an industry leader in scientific skin care breakthrough technologies, and CEO of one of the best selling skin care brands on QVC (for 17 years). She is an author, lecturer (PBS), and has been featured in the New York Times, Time Magazine, Vogue, Glamour, Instyle, Cosmopolitan, Harper’s Bazaar, Lucky Magazine, and many more.